Nikhil Uppal

671 total citations · 1 hit paper
13 papers, 494 citations indexed

About

Nikhil Uppal is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Nikhil Uppal has authored 13 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Nikhil Uppal's work include Pancreatic and Hepatic Oncology Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Nikhil Uppal is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Nikhil Uppal collaborates with scholars based in United States, Canada and India. Nikhil Uppal's co-authors include Manjeshwar Shrinath Baliga, Herbert I. Hurwitz, William M. Garrett, Deborah Hunter, Richard S. Levy, J. Marc Pipas, Zev A. Wainberg, John Nemunaitis, Jason Clark and Stephanie A. Wagner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Nikhil Uppal

13 papers receiving 483 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease

2025 16 citations Jae Hyun Byun, Paul Lebeau et al. Nature Reviews Nephrology profile →

Peers

Countries citing papers authored by Nikhil Uppal

Since Specialization

Citations

This map shows the geographic impact of Nikhil Uppal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikhil Uppal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikhil Uppal more than expected).

Fields of papers citing papers by Nikhil Uppal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikhil Uppal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikhil Uppal. The network helps show where Nikhil Uppal may publish in the future.

Co-authorship network of co-authors of Nikhil Uppal

This figure shows the co-authorship network connecting the top 25 collaborators of Nikhil Uppal. A scholar is included among the top collaborators of Nikhil Uppal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikhil Uppal. Nikhil Uppal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Title	Journal	Authors	Indexed citations
1	Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease breakdown →	Nature Reviews Nephrology	Jae Hyun Byun, Paul Lebeau et al.	16
2	A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors	The Oncologist	Gregory L. Beatty, Safi Shahda et al.	36
3	A phase 1b/2 study of INCB039110 + nab-paclitaxel (N) and gemcitabine (G) in patients (pts) with advanced solid tumors and pancreatic cancer (PC).	Journal of Clinical Oncology	Gregory L. Beatty, Safi Shahda et al.	4
4	Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed	Journal of Clinical Oncology	Herbert I. Hurwitz, Nikhil Uppal et al.	237
5	Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial	Annals of Oncology	H. Hurwitz, Nikhil Uppal et al.	2
6	A randomized double-blind phase 2 study of ruxolitinib (RUX) or placebo (PBO) with capecitabine (CAPE) as second-line therapy in patients (pts) with metastatic pancreatic cancer (mPC).	Journal of Clinical Oncology	Herbert I. Hurwitz, Nikhil Uppal et al.	35
7	A Phase 1/2 Study of At13387, a Heat Shock Protein 90 (Hsp90) Inhibitor in Combination with Abiraterone Acetate (Aa) and Prednisone (P) in Patients (Pts) with Castration-Resistant Prostate Cancer (Mcrpc) No Longer Responding to Aa	Annals of Oncology	Roberta Ferraldeschi, Fred Saad et al.	2
8	Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study	International Journal of Oral and Maxillofacial Surgery	Manjeshwar Shrinath Baliga, Nikhil Uppal et al.	92
9	Venous thromboembolism in patients with diffuse large B-cell lymphoma	Leukemia & lymphoma	Rami S. Komrokji, Nikhil Uppal et al.	65
10	Patterns and Timing of Initial Relapse in Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma.	Blood	Sughosh Dhakal, Tithi Biswas et al.	1
11	2520	International Journal of Radiation OncologyBiologyPhysics	Tithi Biswas, Sheema Chawla et al.	1
12	A Predictive Model for Chemotherapy-Associated Thrombosis Based on Findings from a Prospective Outpatient Registry.	Blood	Alok A. Khorana, Charles W. Francis et al.	1
13	Venous Thromboembolic Events in Patients with Diffuse Large B cell Non- Hodgkin’s Lymphoma.	Blood	Rami S. Komrokji, Nikhil Uppal et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact